Predicting neuroblastoma outcomes with molecular evolution

A research team led by the German Cancer Research Center in Heidelberg, Germany, has discovered that the genetic sequence of a tumor can be read like a molecular clock, traced back to its most recent common ancestor cell. Extracting the duration of tumor evolution can give an accurate predictor of neuroblastoma outcomes.

Leave A Comment

Your email address will not be published. Required fields are marked *